Prevalence and risk factors of irritable bowel syndrome in healthy screenee undergoing colonoscopy and laboratory tests
- PMID: 20535326
- PMCID: PMC2879825
- DOI: 10.5056/jnm.2010.16.1.47
Prevalence and risk factors of irritable bowel syndrome in healthy screenee undergoing colonoscopy and laboratory tests
Abstract
Introduction: The prevalence of irritable bowel syndrome (IBS) after excluding organic disease has not been reported in Korea.
Methods: Of 5,605 participants in a health screening program, inclusion criteria were persons who underwent colonoscopy and completed questionnaires. Exclusion criteria were persons diagnosed with colon cancer, inflammatory bowel disease, previous colectomy, and abnormal results of thyroid function tests. IBS was defined by Rome III criteria. Physical and psychological stress was evaluated with visual analogue scales, ranging from 0 to 10. Risk factors for IBS were estimated with odds ratios (OR) and 95% confidence intervals (CI) using logistic regression analysis.
Results: The prevalence of IBS was 8.2% (5,605) in the total population and 9.1% (393/4,296) in the final study sample. IBS had a positive association with female sex (adjusted OR, 1.33; 95% CI, 1.00-1.79; p = 0.05) and current smoking (adjusted OR, 1.31; 95% CI, 1.00-1.71; p = 0.05). The prevalence of IBS increased with increased psychological stress (adjusted p for trend = 0.005) and decreased with increasing age (adjusted p for trend <0.001), with adjusted OR of 0.95 (95% CI, 0.68-1.33) for age of 40.0 to 49.9 years; 0.79 (95% CI, 0.54-1.15) for age of 50.0 to 59.9 years; and 0.51 (95% CI, 0.30-0.86) for age of 60 years or more, compared with age less than 40 years. Drinking status, body mass index, hypertension, diabetes, and use of sedatives had no association with IBS.
Conclusions: The prevalence of IBS increased with decreasing age and increasing psychological stress, and was positively associated with female sex and current smoking.
Keywords: Colonoscopy; Irritable bowel syndrome; Prevalence; Risk factors.
Conflict of interest statement
Conflicts of interest: None.
Similar articles
-
Irritable bowel syndrome: prevalence, risk factors in an adult Lebanese population.BMC Gastroenterol. 2017 Dec 2;17(1):137. doi: 10.1186/s12876-017-0698-2. BMC Gastroenterol. 2017. PMID: 29197339 Free PMC article.
-
Determinants and frequency of irritable bowel syndrome in a German sample.Z Gastroenterol. 2016 Mar;54(3):217-25. doi: 10.1055/s-0041-106856. Epub 2016 Apr 4. Z Gastroenterol. 2016. PMID: 27043884
-
Predictive value of alarm symptoms in Rome IV irritable bowel syndrome: A multicenter cross-sectional study.World J Clin Cases. 2022 Jan 14;10(2):563-575. doi: 10.12998/wjcc.v10.i2.563. World J Clin Cases. 2022. PMID: 35097082 Free PMC article.
-
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.Clin Gastroenterol Hepatol. 2012 Jul;10(7):712-721.e4. doi: 10.1016/j.cgh.2012.02.029. Epub 2012 Mar 15. Clin Gastroenterol Hepatol. 2012. PMID: 22426087
-
Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol. 2020 Dec;5(12):1053-1062. doi: 10.1016/S2468-1253(20)30300-9. Epub 2020 Oct 2. Lancet Gastroenterol Hepatol. 2020. PMID: 33010814
Cited by
-
Impact of linaclotide treatment on work productivity and activity impairment in adults with irritable bowel syndrome with constipation: results from 2 randomized, double-blind, placebo-controlled phase 3 trials.Am Health Drug Benefits. 2014 Aug;7(5):289-97. Am Health Drug Benefits. 2014. PMID: 25237424 Free PMC article.
-
Personalizing Medical Treatment Decisions: Integrating Meta-analytic Treatment Comparisons with Patient-Specific Risks and Preferences.Med Decis Making. 2019 Nov;39(8):998-1009. doi: 10.1177/0272989X19884927. Epub 2019 Nov 9. Med Decis Making. 2019. PMID: 31707910 Free PMC article.
-
Association of nicotine dependence and gut microbiota: a bidirectional two-sample Mendelian randomization study.Front Immunol. 2023 Nov 7;14:1244272. doi: 10.3389/fimmu.2023.1244272. eCollection 2023. Front Immunol. 2023. PMID: 38022531 Free PMC article.
-
The effects of lifestyle modification on symptoms and quality of life in patients with irritable bowel syndrome: a prospective observational study.Gut Liver. 2011 Dec;5(4):472-7. doi: 10.5009/gnl.2011.5.4.472. Epub 2011 Nov 21. Gut Liver. 2011. PMID: 22195246 Free PMC article.
-
Longer colonic transit time is associated with laxative and drug use, lifestyle factors, and symptoms of constipation.Acta Radiol Open. 2018 Oct 22;7(10):2058460118807232. doi: 10.1177/2058460118807232. eCollection 2018 Sep. Acta Radiol Open. 2018. PMID: 30364803 Free PMC article.
References
-
- Russo MW, Gaynes BN, Drossman DA. A national survey of practice patterns of gastroenterologists with comparison to the past two decades. J Clin Gastroenterol. 1999;29:339–343. - PubMed
-
- Andrews EB, Eaton SC, Hollis KA, et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther. 2005;22:935–942. - PubMed
-
- Lee SY, Lee KJ, Kim SJ, Cho SW. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion. 2009;79:196–201. - PubMed
-
- Han SH, Lee OY, Bae SC, et al. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria. J Gastroenterol Hepatol. 2006;21:1687–1692. - PubMed
LinkOut - more resources
Full Text Sources